activity
20172021
most citedKey Questions for Modelling COVID-19 Exit Strategies

138 citations · 151 across the 4 of their papers we have counts for

collaborators

5 papers

q-bio.PE2021

COVID-19 in low-tolerance border quarantine systems: impact of the Delta variant of SARS-CoV-2

Cameron Zachreson, Freya M. Shearer, David J. Price +4

In controlling transmission of COVID-19, the effectiveness of border quarantine strategies is a key concern for jurisdictions in which the local prevalence of disease and immunity…

q-bio.PE2021

Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure

Somya Mehra, Eva Stadler, David Khoury +2

Malaria is a mosquito-borne disease with a devastating global impact. Plasmodium vivax is a major cause of human malaria beyond sub-Saharan Africa. Relapsing infections, driven by…

q-bio.PE202113 cited

An activation-clearance model for Plasmodium vivax malaria

Somya Mehra, James M. McCaw, Mark B. Flegg +2

Malaria is an infectious disease with an immense global health burden. Plasmodium vivax is the most geographically widespread species of malaria. Relapsing infections, caused by th…

q-bio.OT2020138 cited

Key Questions for Modelling COVID-19 Exit Strategies

Robin N Thompson, T Deirdre Hollingsworth, Valerie Isham +40

Combinations of intense non-pharmaceutical interventions ('lockdowns') were introduced in countries worldwide to reduce SARS-CoV-2 transmission. Many governments have begun to impl…

q-bio.PE2017

Infection-acquired versus vaccine-acquired immunity in an SIRWS model

Tiffany Leung, Barry D Hughes, Federico Frascoli +2

Despite high vaccine coverage, pertussis has re-emerged as a public health concern in many countries. One hypothesis posed for re-emergence is the waning of immunity. In some disea…